INAHTA sessions coming up at the 2019 HTAi conference

INAHTA is pleased to announce that  two official INAHTA sessions will be delivered at the HTAi Annual Meeting in Cologne, 12-15 June 2019.  The sessions are:

–> INAHTA Panel: "Keep Calm and Carry On: INAHTA Members' Views on Planning for Potentially Disruptive Technologies".  Moderator:  Ken Bond (IHE).  Presenters: Claudia Wild (LBI-HTA), Grace Huang (CDE), Michelle Mujoomdar (CADTH), Rossella Di Bidino (UVT-Gemelli), Susanna Axelson (SBU).

–> INAHTA Workshop:  "Health Economics 101: Everyone's an Economist, They Just Don't Know It".  Moderator:  Matthias Perleth (G-BA).  Facilitators: Jeff Round and Gareth Hopkins (IHE), Pia Johansson (SBU).

Additionally, two joint task groups convened and led by INAHTA have had abstracts accepted as well for the HTAi conference:
Joint task group with INAHTA and G-I-N:  "GINAHTA: A Global effort to strengthen the synergy between HTA and clinical practice guidelines".
Joint task group with INAHTA, EUnetHTA, RedETSA and HTAsiaLink:  "HTA Agency Collaboration in the Use of Real World Evidence"

These sessions are just a few of the many sessions that will include INAHTA members at the conference this coming year.  Join us at HTAi 2019!

Dr. Sophie Söderholm Werkö, INAHTA Board Chair, Dr. Mouna Jameleddine, INAHTA Board Director, and Dr Iñaki Gutiérrez-Ibarluzea (Osteba) participated in panel discussions at the Second Regional Health Technology Assessment Policy Forum in Dubai on 17-18 September 2018.

7th ISPOR South Africa Chapter Conference to be held 17-18 September 2018 in Johannesburg, SA

Topic:  Universal Access to Health: The Role of HTA and HEOR

ISPOR SA Chapter Conference 2018 Flyer 2018 08 13

ISPOR SA Chapter Conference 2018 Flyer Short Course

 ISPOR South Africa Chapter Conference 2018 Registration Form



19-21 February 2019
Evaluation of Medical Devices for Product Development and Health Technology Assessment

This 3-day course offered by the York Health Economics Consortium (YHEC) and the Department of Health Sciences and the Centre for Health Economics, UK provides a comprehensive overview of key issues associated with medical devices clinical and economic evaluation and the creative alternative methods available to robustly evaluate them. It is aimed at medical device developers, manufacturers, regulators, healthcare practitioners, analysts, consultants, and health technology assessors interested in optimising the evidence generation processes aimed at informing key decisions they are faced with throughout the full development and evaluation pathway of medical devices.

For more information on course content or how to book, please visit:

INAHTA is pleased to welcome the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) as a full member of INAHTA.

The objective of FinCCHTA is to coordinate HTA in Finland as well as to cooperate with international HTA bodies. Other key objectives are to develop HTA methodological training and strengthen its related research.

Welcome! Tervetuloa!


INAHTA is proud to have world-class leaders in HTA as members of the INAHTA Board.

This year, we welcome a number of new Board members:

Chair: Sophie Söderholm Werkö, SBU, Sweden
Vice Chair: Tracy Merlin, AHTA, Australia
Three new Directors: 
Mouna Jameleddine, INASanté, Tunisia;
Michelle Mujoomdar, CADTH, Canada
Matthias Perleth, G-BA, Germany

These new Board members join Mrs. Debjani (Jani) Mueller, who continues her term as Director to June 2019.
View Board member profiles


INAHTA will have a exhibitor booth at the HTAi Annual Meeting from 1-5 June 2018 (visit conference website).

Come visit us at booth #3 at the beautiful conference venue, the Westin Bayshore, Vancouver, Canada.


INAHTA members are invited to view video recordings of two recent webinars presenting the results of a survey of hot topics in HTA.  This survey gathered views from member agencies about what key issues they face, what learning interests they have and what are some hot topics in their agency and region/country.

View webinar (login required)

On 9 May, 2018, the Utrecht Institute for Pharmaceutical Sciences is hosting an international symposium on the use of real-world evidence (RWE) in drug regulation and health technology assessment (HTA) in Utrecht, the Netherlands.

Registration for the Symposium is required:

For more information:

UIPS_RWE_Sumposium Flyer

UIPS_RWE Symposium Program

IMI GetReal initiative is offering an interactive online course will give an understanding of current techniques, opportunities and challenges for the use of real-world evidence in medicine development.

The learning units will cover the following topics:

  • Overview of the medicine development landscape
  • Real-world evidence generation
  • Real-world evidence synthesis
  • Decision-making and weighing of evidence
  • Demonstrating relative effectiveness to decision-makers

Visit website for more information.